Prostate Cancer - Results from #20400

Current management of advanced and castration resistant prostate cancer - Abstract June 9, 2014

Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer - Abstract June 9, 2014

Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin - Abstract June 9, 2014

Prognostic value of a cell-cycle progression score in men with prostate cancer managed with active surveillance after MRI-guided prostate biopsy - A pilot study - Abstract June 9, 2014

How I do it: Prostate cryoablation (PCry) - Abstract June 9, 2014

The use of health services among elderly patients with stage IV prostate cancer in the initial period following diagnosis - Abstract June 9, 2014

Pattern of occult nodal relapse diagnosed with 18F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy - Abstract June 9, 2014

Obesity and long-term survival after radical prostatectomy - Abstract June 7, 2014

Recent advances in imaging-guided interventions for prostate cancers - Abstract June 7, 2014

Bone health care for patients with prostate cancer receiving androgen deprivation therapy - Abstract June 7, 2014

Screening for prostate cancer: Are digital rectal examinations being performed? - Abstract June 7, 2014

Computer-aided detection of prostate cancer in MRI - Abstract June 7, 2014

Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy - Abstract June 7, 2014

A comparative analysis of prostate cancer pre-treatment characteristics stratified by age - Abstract June 7, 2014

Time and labor costs associated with administration of intravenous bisphosphonates for breast or prostate cancer patients with metastatic bone disease: A time and motion study - Abstract June 7, 2014

Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer - Abstract June 7, 2014

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer - Abstract June 7, 2014

Prostate cancer: Role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy - Abstract June 6, 2014

New developments in the treatment of castration resistant prostate cancer - Abstract June 6, 2014

The impact of prostate cancer on partners: A qualitative exploration - Abstract June 6, 2014

Page 1021 of 1435